web analytics
10.4 C
Munich
Monday, October 25, 2021

Univec Conglomerate Inc (OTCMKTS: UNVC) Moving Northbound as Co Goes Pink Current & Signs LOI to Acquire Accredited Outpatient Mental Health Centers

Univec Conglomerate Inc (OTCMKTS: UNVC) continues to move up steadily in recent days regularly trading several million shares per day and looking to break out of its range just under a dime and take out the $0.165 highs from February. Microcapdaily reported on UNVC earlier this year stating: “There is a lot to get excited about on UNVC which has been rising dramatically thanks to a low float and a tightly held stock structure that’s not selling. The Company is led by Dr. David Dalton, the first black pharmaceutical executive in the chain drug industry and he has assembled an impressive BOD including John C. Peoples, Past Vice President of Merck and Kennneth Grant past Vice President of Johns Hopkins Health System.” 

UNVC has made important progress in recent months and is now “pink current” on OTCMarkets, a major step forward for the Company. They also recently announced the signing of a binding term sheet for the acquisition of accredited outpatient mental health centers in Maryland. These centers are community based centers which provide outpatient mental health counseling treatment for substance abuse and other ancillary services. The acquisition will add in excess of $17million in topline revenue to Univec and is expected to close on or around September 30, 2021 subject to final due diligence and valuation. 

Univec Conglomerate Inc (OTCMKTS: UNVC) is an organization whose mission is to change the way healthcare is delivered in America. We are expanding solutions in the substance abuse arena for medication and to include mental and physical healthcare, telehealth services and technology systems and solutions. Univec treats the patient as a whole to improve outcomes for our patients and clients “Total Wraparound” is the foundation for patient support. 

The Company is led by Dr David Dalton; a visionary who was named as one of the “Top 100 Healthcare Leaders” for 2019 by the International Forum on Advancements in Healthcare.  With 45 years’ experience in the pharmaceutical world, Dr. Dalton served over 18 years as Vice President of Rite Aid, and then founded and served as Chairman, President, CEO of several successful pharmaceutical and pharmaceutical related companies including Mednet, ManagedcareRx, and Sivault Systems. Dr. Dalton is an inductee of three Halls of Fame, has received recognition from several presidents of the United States, and is a recipient of the Senatorial-Medal of Freedom. Dr. Dalton received a Doctor of Pharmacy from West Virginia University School of Pharmacy. In addition to his extensive background in pharmaceutical field, he is a visiting professor and lectures at several schools of pharmacy throughout the United States, and former President of West Virginia University School of Pharmacy Presidential Committee. Dr Dalton has built an impressive BOD for UNVC including John C. Peoples, Past Vice President of Merck as well as Kenneth Grant past Vice President of Johns Hopkins Health System.  

https://twitter.com/eweststockboys/status/1443086805348143104

 

To Find out the inside Scoop on UNVC Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

UNVC

UNVC has an impressive BOD; recently Kenneth Grant was elected to the UNVC BOD. Mr. Grant is a past Vice President of Johns Hopkins Health System. Dr. David Dalton, President/CEO of Univec Conglomerate Inc. states” We are delighted to welcome Kenneth Grant past Vice President of Johns Hopkins Health System to our Board of Directors. He brings extensive knowledge and many years of demonstrated professional skills in supply chain management in healthcare to the company.” Kenneth Grant was also responsible for Community Health Initiatives for the Johns Hopkins Health System. He did oversee over 600 employees responsible for carrying out these important functions. He also had oversight for the procurement of goods and services totaling in excess of $1.0 billion dollars. Over the course of his career Ken has been recognized and has received many awards both local and national.  

JOHN C. PEOPLES past vice president of Merck also recently joined the Board of Directors of Univec Conglomerate Inc. bringing demonstrated professional skills in marketing management. 

On August 16 UNVC announced the signing of a binding term sheet for the acquisition of accredited outpatient mental health centers in Maryland. These centers are community based centers which provide outpatient mental health counseling treatment for substance abuse and other ancillary services. The acquisition will add in excess of $17million in topline revenue to Univec and is expected to close on or around September 30, 2021 subject to final due diligence and valuation.

Dr. David Dalton, CEO of Univec, stated that “This is the beginning of Univec’s business plan for “Wraparound Services” in the mental health and substance abuse environment. We are in the midst of a mental health and substance abuse pandemic and new ideas are needed to address the problem. Univec intends to be at the forefront of delivering targeted care in the mental health arena by treating multiple aspects of the issues.” 

For More on UNVC Subscribe Right Now!

UNVC continues to move up steadily in recent days regularly trading several million shares per day and looking to break out of its range just under a dime and take out the $0.165 highs from February. Microcapdaily reported on UNVC earlier this year stating: “There is a lot to get excited about on UNVC which has been rising dramatically thanks to a low float and a tightly held stock structure that’s not selling. The Company is led by Dr. David Dalton, the first black pharmaceutical executive in the chain drug industry and he has assembled an impressive BOD including John C. Peoples, Past Vice President of Merck and Kennneth Grant past Vice President of Johns Hopkins Health System.” UNVC has made important progress in recent months and is now “pink current” on OTCMarkets, a major step forward for the Company. They also recently announced the signing of a binding term sheet for the acquisition of accredited outpatient mental health centers in Maryland. These centers are community based centers which provide outpatient mental health counseling treatment for substance abuse and other ancillary services. The acquisition will add in excess of $17million in topline revenue to Univec and is expected to close on or around September 30, 2021 subject to final due diligence and valuation. Microcapdaily first reported on UNVC on October 28, 2018 when the stock was around $0.005. We will be updating on UNVC when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with UNVC.

Sign Up now for our 100% FREE Penny Stock Newsletter

Disclosure: we hold no position in UNVC either long or short and we have not been compensated for this article.

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest article

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.